Literature DB >> 31782148

Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways.

Lokman Varisli1,2, Osman Cen3,4, Spiros Vlahopoulos5.   

Abstract

Chloroquines are 4-aminoquinoline-based drugs mainly used to treat malaria. At pharmacological concentrations, they have significant effects on tissue homeostasis, targeting diverse signaling pathways in mammalian cells. A key target pathway is autophagy, which regulates macromolecule turnover in the cell. In addition to affecting cellular metabolism and bioenergetic flow equilibrium, autophagy plays a pivotal role at the interface between inflammation and cancer progression. Chloroquines consequently have critical effects in tissue metabolic activity and importantly, in key functions of the immune system. In this article, we will review the work addressing the role of chloroquines in the homeostasis of mammalian tissue, and the potential strengths and weaknesses concerning their use in cancer therapy.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Autophagy; chloroquine; drug repurposing; inflammation; lysosome; neoplasm

Mesh:

Substances:

Year:  2019        PMID: 31782148      PMCID: PMC7011648          DOI: 10.1111/imm.13160

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  294 in total

Review 1.  The cancer stem-cell signaling network and resistance to therapy.

Authors:  A Carnero; Y Garcia-Mayea; C Mir; J Lorente; I T Rubio; M E LLeonart
Journal:  Cancer Treat Rev       Date:  2016-07-09       Impact factor: 12.111

Review 2.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis.

Authors:  Stephanos Pavlides; Iset Vera; Ricardo Gandara; Sharon Sneddon; Richard G Pestell; Isabelle Mercier; Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Antioxid Redox Signal       Date:  2011-11-17       Impact factor: 8.401

3.  STAT transcript levels in childhood acute lymphoblastic leukemia: STAT1 and STAT3 transcript correlations.

Authors:  Maria Adamaki; Maria Tsotra; Spiros Vlahopoulos; Archontis Zampogiannis; Athanasios G Papavassiliou; Maria Moschovi
Journal:  Leuk Res       Date:  2015-09-11       Impact factor: 3.156

4.  Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells.

Authors:  Anna-Maria G Psarra; Stefan Hermann; George Panayotou; Giannis Spyrou
Journal:  Biochem J       Date:  2009-08-27       Impact factor: 3.857

5.  Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.

Authors:  Kirsteen H Maclean; Frank C Dorsey; John L Cleveland; Michael B Kastan
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

6.  Long-term incubation with proteasome inhibitors (PIs) induces IκBα degradation via the lysosomal pathway in an IκB kinase (IKK)-dependent and IKK-independent manner.

Authors:  Kyoung-Hee Lee; Jiyeong Jeong; Chul-Gyu Yoo
Journal:  J Biol Chem       Date:  2013-10-01       Impact factor: 5.157

7.  NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria.

Authors:  Zhenyu Zhong; Atsushi Umemura; Elsa Sanchez-Lopez; Shuang Liang; Shabnam Shalapour; Jerry Wong; Feng He; Daniela Boassa; Guy Perkins; Syed Raza Ali; Matthew D McGeough; Mark H Ellisman; Ekihiro Seki; Asa B Gustafsson; Hal M Hoffman; Maria T Diaz-Meco; Jorge Moscat; Michael Karin
Journal:  Cell       Date:  2016-02-25       Impact factor: 41.582

Review 8.  Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis.

Authors:  Rani Ojha; Shalmoli Bhattacharyya; Shrawan K Singh
Journal:  Biores Open Access       Date:  2015-01-01

9.  Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2-Signal Transducer and Activator of Transcription 3 Pathway.

Authors:  Kai Hu; Yongqiang Yang; Ling Lin; Qing Ai; Jie Dai; Kerui Fan; Pu Ge; Rong Jiang; Jingyuan Wan; Li Zhang
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

10.  Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner.

Authors:  Takouhie Mgrditchian; Tsolere Arakelian; Jérôme Paggetti; Muhammad Zaeem Noman; Elodie Viry; Etienne Moussay; Kris Van Moer; Stephanie Kreis; Coralie Guerin; Stephanie Buart; Caroline Robert; Christophe Borg; Philippe Vielh; Salem Chouaib; Guy Berchem; Bassam Janji
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

View more
  21 in total

1.  Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft Tumors.

Authors:  Jaclyn Lopiccolo; Shigeru Kawabata; Joell J Gills; Phillip A Dennis
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Myristoylated TMEM39AS41, a cell-permeable peptide, causes lung cancer cell death.

Authors:  Sungjin Park; Minhee Kim; Youngeun Hong; Hyunji Lee; Quangdon Tran; Chaeyeong Kim; So Hee Kwon; Jisoo Park; Jongsun Park; Seon-Hwan Kim
Journal:  Toxicol Res       Date:  2020-02-07

Review 3.  Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia.

Authors:  Garrett M Dancik; Ioannis F Voutsas; Spiros Vlahopoulos
Journal:  Mol Biol Rep       Date:  2022-01-14       Impact factor: 2.316

4.  Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.

Authors:  Gaku Tsuji; Ayako Takai-Yumine; Takahiro Kato; Masutaka Furue
Journal:  Cell Death Dis       Date:  2021-05-19       Impact factor: 8.469

5.  Guide to Immunopharmacology: a database to boost immunology education, research and therapy.

Authors:  Simon Milling; Michael Spedding; Pasquale Maffia
Journal:  Immunology       Date:  2020-05       Impact factor: 7.397

Review 6.  Chloroquine against malaria, cancers and viral diseases.

Authors:  Wenmin Zhou; Hui Wang; Yuqi Yang; Zhe-Sheng Chen; Chang Zou; Jianye Zhang
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

Review 7.  Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity.

Authors:  Siya Kamat; Madhuree Kumari
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

8.  Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors.

Authors:  Dijana Drača; Milan Marković; Marta Gozzi; Sanja Mijatović; Danijela Maksimović-Ivanić; Evamarie Hey-Hawkins
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

Review 9.  Co-targeting of lysosome and mitophagy in cancer stem cells with chloroquine analogues and antibiotics.

Authors:  Md Abdul Alim Al-Bari
Journal:  J Cell Mol Med       Date:  2020-09-15       Impact factor: 5.310

10.  Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug-Gene Interactions.

Authors:  Vlad Groza; Mihai Udrescu; Alexandru Bozdog; Lucreţia Udrescu
Journal:  Pharmaceutics       Date:  2021-12-08       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.